NCT06285357
Recruiting
N/A
A Pilot Study to Test the Effect of the Association of Epigallocatechin Gallate (EGCG), Folic Acid and Vitamin B12 in Preventing the Persistence of Human Papilloma Virus (HPV) Infection.
ConditionsHPV Infection
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- HPV Infection
- Sponsor
- Lo.Li.Pharma s.r.l
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- HPV DNA test negativity
- Status
- Recruiting
- Last Updated
- 5 months ago
Overview
Brief Summary
The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.
Investigators
Eligibility Criteria
Inclusion Criteria
- •HR-HPV DNA test positivity
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
HPV DNA test negativity
Time Frame: 8 months of treatment
Percentage
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
N/A
A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.Metabolic SyndromeNCT06158152Industrial Farmacéutica Cantabria, S.A.48
Completed
N/A
An Exploratory Investigation of Dietary Supplementation and Its EffectQuality of LifeNCT05037877HUM Nutrition, Inc.110
Completed
N/A
Pilot study to investigate dietary supplementation of elderly COPD patients with an oral nutritional supplement enriched with n-3 polyunsaturated fatty acids and its effect on respiratory function, appetite and weightISRCTN16343749Department of Health
Terminated
Phase 4
Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Muscle Strength in Hip FractureHip FracturesNCT01850251Hospital Clinic of Barcelona2
Completed
N/A
A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience.Digestive System DiseaseNCT06283732Amway Corp70